查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
卵巢癌症的全球市场 - 市场占有率，规模，趋势，产业分析:各类型，各诊断，各治疗法，各终端用户，各地区，市场区隔预测(2022年～2030年)
市场调查报告书
商品编码
1150072

卵巢癌症的全球市场 - 市场占有率，规模，趋势，产业分析:各类型，各诊断，各治疗法，各终端用户，各地区，市场区隔预测(2022年～2030年)

Ovarian Cancer Market Share, Size, Trends, Industry Analysis Report, By Type ; By Diagnosis; By Therapeutic Treatment; By End-User; By Region; Segment Forecast, 2022 - 2030
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2个工作天内

价格

全球卵巢癌症的市场规模，预计至2030年达到96亿7,000万美元。

本报告提供全球卵巢癌症市场相关调查分析，市场动态，市场区隔分析，地区分析，企业简介等系统性资讯。

目录

第1章 简介

  • 报告说明
    • 调查目的
    • 市场范围
    • 前提条件
  • 相关利益者

第2章 摘要整理

  • 市场概况

第3章 调查手法

  • 概要
    • 资料探勘
  • 资料来源
    • 一次来源
    • 二次来源

第4章 全球卵巢癌症市场洞察

  • 卵巢癌症:产业的概述
  • 卵巢癌症市场动态
    • 促进因素和机会
    • 阻碍因素与课题
  • 波特的五力分析
    • 供给企业谈判力(中)
    • 新加入厂商的威胁(低)
    • 买方议价能力(中)
    • 替代品的威胁(中)
    • 现有企业间的竞争力(高)
  • 大环境分析
  • 卵巢癌症产业趋势
  • 价值链分析
  • COVID-19影响分析

第5章 全球卵巢癌症市场:各诊断

  • 主要的调查结果
  • 简介
    • 各诊断:2018年～2030年
  • 电脑断层摄影(CT)扫描
    • 各电脑断层摄影(CT)扫描
  • 超音波
    • 各超音波，各地区:2018年～2030年
  • 钡灌肠X光
    • 各钡灌肠X光，各地区:2018年～2030年
  • 核磁共振影像(MRI)扫描
    • 各核磁共振影像(MRI)扫描，各地区:2018年～2030年
  • 胸部X光
    • 各胸部X光，各地区:2018年～2030年
  • 正子放出断层摄影法(PET)扫描
    • 各正子放出断层摄影法(PET)扫描，各地区:2018年～2030年
  • 其他的诊断试验
    • 其他的各诊断试验，各地区:2018年～2030年

第6章 全球卵巢癌症市场:各治疗法

  • 主要的调查结果
  • 简介
    • 各治疗法:2018年～2030年
  • 化疗
    • 各化疗，各地区:2018年～2030年
  • 放射线治疗
    • 各放射线治疗，各地区:2018年～2030年
  • 标靶治疗
    • 各标靶治疗，各地区:2018年～2030年
  • 荷尔蒙疗法
    • 各荷尔蒙疗法，各地区:2018年～2030年
  • 其他的治疗方法
    • 其他的各治疗法，各地区:2018年～2030年
  • 手术
    • 各手术，各地区:2018年～2030年

第7章 全球卵巢癌症市场:各类型

  • 主要的调查结果
  • 简介
    • 各类型:2018年～2030年
  • 表皮性肿瘤
    • 各表皮性肿瘤，各地区:2018年～2030年
  • 生殖细胞瘤瘤
    • 各生殖细胞瘤瘤，各地区:2018年～2030年
  • 间品质性肿瘤
    • 各间品质性肿瘤，各地区:2018年～2030年
  • 原发性腹膜癌症
    • 各原发性腹膜癌症，各地区:2018年～2030年

第8章 全球卵巢癌症市场:各终端用户

  • 主要的调查结果
  • 简介
    • 各终端用户:2018年～2030年
  • 医院
    • 各医院，各地区:2018年～2030年
  • 诊断中心
    • 各诊断中心，各地区:2018年～2030年
  • 药妆店
    • 各药妆店，各地区:2018年～2030年
  • 线上药局
    • 各线上药局，各地区:2018年～2030年
  • 其他的终端用户
    • 其他的各终端用户，各地区:2018年～2030年

第9章 全球卵巢癌症市场:各地区

  • 主要的调查结果
  • 简介
    • 卵巢癌症市场评估 - 各地区:2018年～2030年
  • 北美
    • 各诊断:2018年～2030年
    • 各终端用户:2018年～2030年
    • 各治疗法:2018年～2030年
    • 各类型:2018年～2030年
    • 美国
    • 加拿大
  • 欧洲
    • 各诊断:2018年～2030年
    • 各终端用户:2018年～2030年
    • 各治疗法:2018年～2030年
    • 各类型:2018年～2030年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
  • 亚太地区
    • 各诊断:2018年～2030年
    • 各终端用户:2018年～2030年
    • 各治疗法:2018年～2030年
    • 各类型:2018年～2030年
    • 中国
    • 印度
    • 日本
    • 马来西亚
    • 印尼
    • 韩国
  • 中东、非洲
    • 各诊断:2018年～2030年
    • 各终端用户:2018年～2030年
    • 各治疗法:2018年～2030年
    • 各类型:2018年～2030年
    • 沙乌地阿拉伯
    • 南非
    • 以色列
    • 阿拉伯联合大公国
  • 南美
    • 各诊断:2018年～2030年
    • 各终端用户:2018年～2030年
    • 各治疗法:2018年～2030年
    • 各类型:2018年～2030年
    • 墨西哥
    • 巴西
    • 阿根廷

第10章 竞争情形

  • 事业扩张和收购的分析
    • 事业扩张
    • 收购
  • 联盟/合作/协定/展示会

第11章 企业简介

  • AstraZeneca Inc.
  • Aetera Zenteris Inc
  • Bristol-Myers Squibb Corp
  • Boehringer Ingelheim GmbH
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • Genentech Inc
  • Johnson & Johnson Corp
  • Janssen Pharmaceuticals, Inc.
  • Novogen, Inc
  • Oasmia Pharmaceutical Inc
  • Pfizer Inc
  • Roche Ltd.
  • Tesaro Inc.
Product Code: PM1369

The global ovarian cancer market is expected to reach USD 9.67 billion by 2030, according to a new study by Polaris Market Research. The report "Ovarian Cancer Market Share, Size, Trends, Industry Analysis Report, By Type (Epithelial Tumors, Germ Cell Tumors, Stromal Tumors, and Primary Peritoneal Cancer); By Diagnosis; By Therapeutic Treatment; By End-User; By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Market expansion is anticipated to be fueled by the growing emphasis on early diagnosis and treatment and rising FDA approvals for the treatment. The disease prognosis is still bleak because most patients only receive advanced-stage diagnoses. For instance, in November 2021, an imaging medication called Cytalux (pafolacianine), meant to help surgeons spot ovarian cancer lesions, received approval from the U.S. Food and Drug Administration. The medication makes it easier to find extra ovarian malignant tissue, which is typically challenging during surgery.

Further, in May 2020, the FDA authorized Lynparza in conjunction with bevacizumab as the initial maintenance therapy for adult patients with advanced epithelial ovarian, fallopian tube, or principal peritoneal cancer, according to an alliance from AstraZeneca and Merck. Therefore, there is a critical need for an in-depth study of disease biology to create potent therapeutic choices to overcome resistance and reduce toxicity.

The market is expected to be driven by increased government initiatives, rising R&D activities in cancer research, and the ease of use of new treatments and therapies. For instance, the Ovarian Cancer Research Alliance (OCRA), a non-profit group, focuses on cancer research and development. Top researchers at 79 eminent medical centers have received 349 grants totaling $110 million from OCRA, ensuring that research into ovarian cancer continues to advance the field and prepare the way for a solution. It funds several research initiatives aimed at identifying and treating this condition. Thus, these factors bolster industry growth during the forecast period.

Healthcare is expanding as a result of the rising economy of the nations in both developed and emerging regions. The industry is expected to continue to increase during the forecast period due to factors such as the rising incidence of ovarian cancer and the growing number of elderly women. According to the National Institute of Health, 604 million old women will exist worldwide by 2025.

Ovarian Cancer Market Report Highlights

Targeted therapy is anticipated to grow rapidly over the forecast period because it interfaces with specific proteins in tumorigenesis by focusing on molecular changes which stop the growth of various types of cancers. Also, targeted medicines are becoming more and more popular.

CT Scans segment accounted for a higher revenue share. Due to its capacity to shed light on tumor dissemination, CT scan demand in cancer diagnostics is anticipated to rise.

Asia-Pacific is expected to grow faster over the projected period due to the increasing prevalence of the geriatric population in emerging economies, improved healthcare infrastructure, rising disposable income, and increased consumer awareness regarding health.

The global market is highly competitive owing to the existence of significant players with a global presence, including AstraZeneca Inc., Eli Lilly and Company, GlaxoSmithKline plc, Johnson & Johnson Corp., Janssen Pharmaceuticals, Inc., Novogen, Inc., Oasmia Pharmaceutical Inc, Pfizer Inc., Roche Ltd., and Tesaro Inc.

Polaris Market Research has segmented the Ovarian Cancer market report based on type, diagnosis, therapeutic treatment, end-user, and region:

Ovarian Cancer, Type Outlook (Revenue - USD Billion, 2018 - 2030)

Epithelial Tumors

Germ Cell Tumors

Stromal Tumors

Primary Peritoneal Cancer

Ovarian Cancer, Diagnosis Outlook (Revenue - USD Billion, 2018 - 2030)

Computed Tomography (C.T.) Scans

Ultrasound

Barium Enema X-Ray

Magnetic Resonance Imaging (MRI) Scans

Chest X-Ray

Positron Emission Tomography (PET) Scan

Other Diagnostic Tests

Ovarian Cancer, Therapeutic Treatment Outlook (Revenue - USD Billion, 2018 - 2030)

Chemotherapy

Radiation Therapy

Targeted Therapy

Hormone Therapy

Other Therapeutic Treatments

Surgery

Ovarian Cancer, End-User Outlook (Revenue - USD Billion, 2018 - 2030)

Hospitals

Diagnostic Centers

Drug Stores

Online Pharmacies

Other End Users

Ovarian Cancer, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

North America

U.S

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Ovarian Cancer Market Insights

  • 4.1. Ovarian Cancer - Industry Snapshot
  • 4.2. Ovarian Cancer Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rise in the Elderly women's population
      • 4.2.1.2. Rising healthcare awareness is accelerating the market
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Ignorance of the symptoms of Ovarian Cancer may drag down the market
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Ovarian Cancer Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Ovarian Cancer Market, by Diagnosis

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
  • 5.3. Computed Tomography (C.T.) Scans
    • 5.3.1. Global Ovarian Cancer Market, by Computed Tomography (C.T.) Scans, by Region, 2018 - 2030 (USD Billion)
  • 5.4. Ultrasound
    • 5.4.1. Global Ovarian Cancer Market, by Ultrasound, by Region, 2018 - 2030 (USD Billion)
  • 5.5. Barium Enema X-Ray
    • 5.5.1. Global Ovarian Cancer Market, by Barium Enema X-Ray, by Region, 2018 - 2030 (USD Billion)
  • 5.6. Magnetic Resonance Imaging (MRI) Scans
    • 5.6.1. Global Ovarian Cancer Market, by Magnetic Resonance Imaging (MRI) Scans, by Region, 2018 - 2030 (USD Billion)
  • 5.7. Chest X-Ray
    • 5.7.1. Global Ovarian Cancer Market, by Chest X-Ray, by Region, 2018 - 2030 (USD Billion)
  • 5.8. Positron Emission Tomography (PET) Scan
    • 5.8.1. Global Ovarian Cancer Market, by Positron Emission Tomography (PET) Scan, by Region, 2018 - 2030 (USD Billion)
  • 5.9. Other Diagnostic Tests
    • 5.9.1. Global Ovarian Cancer Market, by Other Diagnostic Tests, by Region, 2018 - 2030 (USD Billion)

6. Global Ovarian Cancer Market, by Therapeutic Treatment

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
  • 6.3. Chemotherapy
    • 6.3.1. Global Ovarian Cancer Market, by Chemotherapy, by Region, 2018 - 2030 (USD Billion)
  • 6.4. Radiation Therapy
    • 6.4.1. Global Ovarian Cancer Market, by Radiation Therapy, by Region, 2018 - 2030 (USD Billion)
  • 6.5. Targeted Therapy
    • 6.5.1. Global Ovarian Cancer Market, by Targeted Therapy, by Region, 2018 - 2030 (USD Billion)
  • 6.6. Hormone Therapy
    • 6.6.1. Global Ovarian Cancer Market, by Hormone Therapy, by Region, 2018 - 2030 (USD Billion)
  • 6.7. Other Therapeutic Treatments
    • 6.7.1. Global Ovarian Cancer Market, by Other Therapeutic Treatments, by Region, 2018 - 2030 (USD Billion)
  • 6.8. Surgery
    • 6.8.1. Global Ovarian Cancer Market, by Surgery, by Region, 2018 - 2030 (USD Billion)

7. Global Ovarian Cancer Market, by Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
  • 7.3. Epithelial Tumors
    • 7.3.1. Global Ovarian Cancer Market, by Epithelial Tumors, by Region, 2018 - 2030 (USD Billion)
  • 7.4. Germ Cell Tumors
    • 7.4.1. Global Ovarian Cancer Market, by Germ Cell Tumors, by Region, 2018 - 2030 (USD Billion)
  • 7.5. Stromal Tumors
    • 7.5.1. Global Ovarian Cancer Market, by Stromal Tumors, by Region, 2018 - 2030 (USD Billion)
  • 7.6. Primary Peritoneal Cancer
    • 7.6.1. Global Ovarian Cancer Market, by Primary Peritoneal Cancer, by Region, 2018 - 2030 (USD Billion)

8. Global Ovarian Cancer Market, by End-User

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
  • 8.3. Hospitals
    • 8.3.1. Global Ovarian Cancer Market, by Hospitals, by Region, 2018 - 2030 (USD Billion)
  • 8.4. Diagnostic Centers
    • 8.4.1. Global Ovarian Cancer Market, by Diagnostic Centers, by Region, 2018 - 2030 (USD Billion)
  • 8.5. Drug Stores
    • 8.5.1. Global Ovarian Cancer Market, by Drug Stores, by Region, 2018 - 2030 (USD Billion)
  • 8.6. Online Pharmacies
    • 8.6.1. Global Ovarian Cancer Market, by Online Pharmacies, by Region, 2018 - 2030 (USD Billion)
  • 8.7. Other End Users
    • 8.7.1. Global Ovarian Cancer Market, by Other End Users, by Region, 2018 - 2030 (USD Billion)

9. Global Ovarian Cancer Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Ovarian Cancer Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • 9.3. Ovarian Cancer Market - North America
    • 9.3.1. North America: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
    • 9.3.2. North America: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
    • 9.3.3. North America: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
    • 9.3.4. North America: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
    • 9.3.5. Ovarian Cancer Market - U.S.
      • 9.3.5.1. U.S.: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
      • 9.3.5.2. U.S.: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.3.5.3. U.S.: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
      • 9.3.5.4. U.S.: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
    • 9.3.6. Ovarian Cancer Market - Canada
      • 9.3.6.1. Canada: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
      • 9.3.6.2. Canada: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.3.6.3. Canada: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
      • 9.3.6.4. Canada: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
  • 9.4. Ovarian Cancer Market - Europe
    • 9.4.1. Europe: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
    • 9.4.2. Europe: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
    • 9.4.3. Europe: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
    • 9.4.4. Europe: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
    • 9.4.5. Ovarian Cancer Market - UK
      • 9.4.5.1. UK: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
      • 9.4.5.2. UK: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.4.5.3. UK: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
      • 9.4.5.4. UK: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
    • 9.4.6. Ovarian Cancer Market - France
      • 9.4.6.1. France: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
      • 9.4.6.2. France: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.4.6.3. France: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
      • 9.4.6.4. France: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
    • 9.4.7. Ovarian Cancer Market - Germany
      • 9.4.7.1. Germany: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
      • 9.4.7.2. Germany: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.4.7.3. Germany: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
      • 9.4.7.4. Germany: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
    • 9.4.8. Ovarian Cancer Market - Italy
      • 9.4.8.1. Italy: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
      • 9.4.8.2. Italy: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.4.8.3. Italy: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
      • 9.4.8.4. Italy: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
    • 9.4.9. Ovarian Cancer Market - Spain
      • 9.4.9.1. Spain: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
      • 9.4.9.2. Spain: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.4.9.3. Spain: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
      • 9.4.9.4. Spain: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
    • 9.4.10. Ovarian Cancer Market - Netherlands
      • 9.4.10.1. Netherlands: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
      • 9.4.10.2. Netherlands: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.4.10.3. Netherlands: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
      • 9.4.10.4. Netherlands: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
    • 9.4.11. Ovarian Cancer Market - Russia
      • 9.4.11.1. Russia: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
      • 9.4.11.2. Russia.: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.4.11.3. Russia: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
      • 9.4.11.4. Russia: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
  • 9.5. Ovarian Cancer Market - Asia Pacific
    • 9.5.1. Asia Pacific: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
    • 9.5.2. Asia Pacific: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
    • 9.5.3. Asia Pacific: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
    • 9.5.4. Asia Pacific: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
    • 9.5.5. Ovarian Cancer Market - China
      • 9.5.5.1. China: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
      • 9.5.5.2. China.: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.5.5.3. China: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
      • 9.5.5.4. China: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
    • 9.5.6. Ovarian Cancer Market - India
      • 9.5.6.1. India: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
      • 9.5.6.2. India.: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.5.6.3. India: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
      • 9.5.6.4. India: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
    • 9.5.7. Ovarian Cancer Market - Japan
      • 9.5.7.1. Japan: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
      • 9.5.7.2. Japan.: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.5.7.3. Japan: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
      • 9.5.7.4. Japan: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
    • 9.5.8. Ovarian Cancer Market - Malaysia
      • 9.5.8.1. Malaysia: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
      • 9.5.8.2. Malaysia.: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.5.8.3. Malaysia: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
      • 9.5.8.4. Malaysia: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
    • 9.5.9. Ovarian Cancer Market - Indonesia
      • 9.5.9.1. Indonesia: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
      • 9.5.9.2. Indonesia.: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.5.9.3. Indonesia: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
      • 9.5.9.4. Indonesia: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
    • 9.5.10. Ovarian Cancer Market - South Korea
      • 9.5.10.1. South Korea: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
      • 9.5.10.2. South Korea.: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.5.10.3. South Korea: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
      • 9.5.10.4. South Korea: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
  • 9.6. Ovarian Cancer Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
    • 9.6.2. Middle East & Africa: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
    • 9.6.3. Middle East & Africa: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
    • 9.6.4. Middle East & Africa: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
    • 9.6.5. Ovarian Cancer Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
    • 9.6.6. Ovarian Cancer Market - South Africa
      • 9.6.6.1. South Africa: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
      • 9.6.6.2. South Africa: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.6.6.3. South Africa: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
      • 9.6.6.4. South Africa: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
    • 9.6.7. Ovarian Cancer Market - Israel
      • 9.6.7.1. Israel: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
      • 9.6.7.2. Israel: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.6.7.3. Israel: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
      • 9.6.7.4. Israel: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
    • 9.6.8. Ovarian Cancer Market - UAE
      • 9.6.8.1. UAE: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
      • 9.6.8.2. UAE: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.6.8.3. UAE: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
      • 9.6.8.4. UAE: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
  • 9.7. Ovarian Cancer Market - Latin America
    • 9.7.1. Latin America: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
    • 9.7.2. Latin America: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
    • 9.7.3. Latin America: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
    • 9.7.4. Latin America: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
    • 9.7.5. Ovarian Cancer Market - Mexico
      • 9.7.5.1. Mexico: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
      • 9.7.5.2. Mexico: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.7.5.3. Mexico: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
      • 9.7.5.4. Mexico: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
    • 9.7.6. Ovarian Cancer Market - Brazil
      • 9.7.6.1. Brazil: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
      • 9.7.6.2. Brazil: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.7.6.3. Brazil: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
      • 9.7.6.4. Brazil: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
    • 9.7.7. Ovarian Cancer Market - Argentina
      • 9.7.7.1. Argentina: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
      • 9.7.7.2. Argentina: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.7.7.3. Argentina: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
      • 9.7.7.4. Argentina: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. AstraZeneca Inc.
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Aetera Zenteris Inc
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Bristol-Myers Squibb Corp
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Boehringer Ingelheim GmbH
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Eli Lilly and Company
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. GlaxoSmithKline plc
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Genentech Inc
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Johnson & Johnson Corp
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Janssen Pharmaceuticals, Inc.
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Novogen, Inc
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Oasmia Pharmaceutical Inc
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Pfizer Inc
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Roche Ltd.
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Tesaro Inc.
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development

List of Tables

  • Table 1 Global Ovarian Cancer Market, by Diagnosis, by Region, 2018 - 2030 (USD Billion)
  • Table 2 Global Ovarian Cancer Market, by Therapeutic Treatment, by Region, 2018 - 2030 (USD Billion)
  • Table 3 Global Ovarian Cancer Market, by Type, by Region, 2018 - 2030 (USD Billion)
  • Table 4 Global Ovarian Cancer Market, by End-User, by Region, 2018 - 2030 (USD Billion)
  • Table 5 Ovarian Cancer Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • Table 6 North America: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
  • Table 7 North America: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
  • Table 8 North America: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
  • Table 9 North America: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 10 U.S.: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
  • Table 11 U.S.: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
  • Table 12 U.S.: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
  • Table 13 U.S.: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 14 Canada: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
  • Table 15 Canada: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
  • Table 16 Canada: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
  • Table 17 Canada: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 18 Europe: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
  • Table 19 Europe: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
  • Table 20 Europe: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
  • Table 21 Europe: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 22 Germany: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
  • Table 23 Germany: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
  • Table 24 Germany: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
  • Table 25 Germany: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 26 France: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
  • Table 27 France: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
  • Table 28 France: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
  • Table 29 France: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 30 UK: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
  • Table 31 UK: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
  • Table 32 UK: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
  • Table 33 UK: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 34 Italy: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
  • Table 35 Italy: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
  • Table 36 Italy: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
  • Table 37 Italy: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 38 Netherlands: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
  • Table 39 Netherlands: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
  • Table 40 Netherlands: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
  • Table 41 Netherlands: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 42 Spain: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
  • Table 43 Spain: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
  • Table 44 Spain: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
  • Table 45 Spain: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 46 Russia: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
  • Table 47 Russia: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
  • Table 48 Russia: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
  • Table 49 Russia: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 50 Asia Pacific: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
  • Table 51 Asia Pacific: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
  • Table 52 Asia Pacific: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
  • Table 53 Asia Pacific: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 54 China: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
  • Table 55 China: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
  • Table 56 China: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
  • Table 57 China: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 58 Japan: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
  • Table 59 Japan: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
  • Table 60 Japan: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
  • Table 61 Japan: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 62 India: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
  • Table 63 India: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
  • Table 64 India: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
  • Table 65 India: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 66 Indonesia: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
  • Table 67 Indonesia: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
  • Table 68 Indonesia: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
  • Table 69 Indonesia: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 70 Malaysia: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
  • Table 71 Malaysia: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
  • Table 72 Malaysia: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
  • Table 73 Malaysia: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 74 South Korea: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
  • Table 75 South Korea: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
  • Table 76 South Korea: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
  • Table 77 South Korea: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 78 Latin America: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
  • Table 79 Latin America: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
  • Table 80 Latin America: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
  • Table 81 Latin America: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 82 Brazil: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
  • Table 83 Brazil: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
  • Table 84 Brazil: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
  • Table 85 Brazil: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 86 Mexico: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
  • Table 87 Mexico: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
  • Table 88 Mexico: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
  • Table 89 Mexico: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 90 Argentina: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
  • Table 91 Argentina: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
  • Table 92 Argentina: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
  • Table 93 Argentina: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 94 Middle East & Africa: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
  • Table 95 Middle East & Africa: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
  • Table 96 Middle East & Africa: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
  • Table 97 Middle East & Africa: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 98 UAE: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
  • Table 99 UAE: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
  • Table 100 UAE: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
  • Table 101 UAE: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 102 Saudi Arabia: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
  • Table 103 Saudi Arabia: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
  • Table 104 Saudi Arabia: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
  • Table 105 Saudi Arabia: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 106 South Africa: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
  • Table 107 South Africa: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
  • Table 108 South Africa: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
  • Table 109 South Africa: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 110 Israel: Ovarian Cancer Market, by Diagnosis, 2018 - 2030 (USD Billion)
  • Table 111 Israel: Ovarian Cancer Market, by Therapeutic Treatment, 2018 - 2030 (USD Billion)
  • Table 112 Israel: Ovarian Cancer Market, by Type, 2018 - 2030 (USD Billion)
  • Table 113 Israel: Ovarian Cancer Market, by End-User, 2018 - 2030 (USD Billion)

List of Figures

Figure 1. Global Ovarian Cancer Market, 2018 - 2030 (USD Billion)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up End-User

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Diagnosis

Figure 7. Global Ovarian Cancer Market, by Diagnosis, 2021 & 2030 (USD Billion)

Figure 8. Market by End-User

Figure 9. Global Ovarian Cancer Market, by End-User, 2021 & 2030 (USD Billion)

Figure 10. Market by Therapeutic Treatment

Figure 11. Global Ovarian Cancer Market, by Therapeutic Treatment, 2021 & 2030 (USD Billion)

Figure 12. Market by Type

Figure 13. Global Ovarian Cancer Market, by Type, 2021 & 2030 (USD Billion)

Figure 14. Ovarian Cancer Market Assessment, By Geography, 2018 - 2030 (USD Billion)

Figure 15. Strategic Analysis - Ovarian Cancer Market